Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Shares Outstanding (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Shares Outstanding for 7 consecutive years, with $66.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 23.37% to $66.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66.6 million through Dec 2025, up 23.37% year-over-year, with the annual reading at $66.6 million for FY2025, 23.37% up from the prior year.
  • Shares Outstanding for Q4 2025 was $66.6 million at Fulcrum Therapeutics, up from $54.1 million in the prior quarter.
  • The five-year high for Shares Outstanding was $66.6 million in Q4 2025, with the low at $21.0 in Q2 2021.
  • Average Shares Outstanding over 5 years is $50.4 million, with a median of $54.0 million recorded in 2024.
  • The sharpest move saw Shares Outstanding plummeted 100.0% in 2021, then soared 195277066.67% in 2022.
  • Over 5 years, Shares Outstanding stood at $40.6 million in 2021, then rose by 28.24% to $52.1 million in 2022, then rose by 18.84% to $61.9 million in 2023, then dropped by 12.84% to $54.0 million in 2024, then rose by 23.37% to $66.6 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $66.6 million, $54.1 million, and $54.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.